SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
SEC Accession No. 0001193125-15-340768
Filing Date
2015-10-09
Accepted
2015-10-09 06:09:11
Documents
4
Group Members
ABG II-WX LTDBOYU CAPITAL FUND II, L.P.DR. GE LIDR. NING ZHAOG&C PARTNERSHIP L.P.HILLHOUSE CAPITAL FUND II, L.P.MR. XIAOZHONG LIUMR. ZHAOHUI ZHANGNEW WUXI LIFE SCIENCE HOLDINGS LTDNEW WUXI LIFE SCIENCE LTDPING AN LIFE INSURANCE CO OF CHINA LTD.TEMASEK LIF

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.2 TO SCHEDULE 13E-3 d86213dsc13e3a.htm SC 13E3/A 215767
2 EX-99.(A)(1) d86213dex99a1.htm EX-99.(A)(1) 1770401
3 GRAPHIC g86213g41a45.jpg GRAPHIC 30145
4 GRAPHIC g86213g67j54.jpg GRAPHIC 38439
  Complete submission text file 0001193125-15-340768.txt   2082896
Mailing Address 288 FUTE ZHONG ROAD WAIGAOQIAO FREE TRADE ZONE SHANGHAI F4 200131
Business Address 288 FUTE ZHONG ROAD WAIGAOQIAO FREE TRADE ZONE SHANGHAI F4 200131 86-21-5046-1111
WuXi PharmaTech (Cayman) Inc. (Filed by) CIK: 0001403132 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13E3/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 288 FUTE ZHONG ROAD WAIGAOQIAO FREE TRADE ZONE SHANGHAI F4 200131
Business Address 288 FUTE ZHONG ROAD WAIGAOQIAO FREE TRADE ZONE SHANGHAI F4 200131 86-21-5046-1111
WuXi PharmaTech (Cayman) Inc. (Subject) CIK: 0001403132 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13E3/A | Act: 34 | File No.: 005-83350 | Film No.: 151151921
SIC: 2834 Pharmaceutical Preparations